Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT03128866
EARLY_PHASE1
Tranexamic Acid in Reducing Blood Loss in Patients With Pelvic Tumors Undergoing Hemipelvectomy Surgery
Sponsor: M.D. Anderson Cancer Center
View on ClinicalTrials.gov
Summary
This early phase I trial studies how well tranexamic acid works in reducing the loss of blood in patients with pelvic tumors undergoing hemipelvectomy surgery. Tranexamic acid decreases blood loss by stabilizing clots and preventing clot lysis in patients undergoing surgery.
Official title: Reducing Blood Loss in Hemipelvectomy Surgery With the Use Tranexamic Acid (TXA)
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2017-05-19
Completion Date
2026-05-31
Last Updated
2026-03-05
Healthy Volunteers
No
Conditions
Interventions
PROCEDURE
Hemipelvectomy
Undergo hemipelvectomy
DRUG
Tranexamic Acid
Given IV
Locations (1)
M D Anderson Cancer Center
Houston, Texas, United States